In Entwicklung
Business·2.6.2026KI-Zusammenfassung
Alkem Laboratories Launches Semaglutide in Pre-filled Syringes in India
Alkem Laboratories launched semaglutide in single-shot pre-filled syringes in India, making diabetes and obesity treatment more accessible and affordable. The company is the first in India to offer this format, intensifying competition in the growing drug market.
E
Economic Times3 Min. Lesezeit